RecruitingPhase 4NCT07315191
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Studying Immunoglobulin A vasculitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Capital Institute of Pediatrics, China
- Intervention
- ACEI / ARB+finerenone(drug)
- Enrollment
- 116 target
- Eligibility
- 3-18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- Capital Center for Children's Health,Capital Medical University, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07315191 on ClinicalTrials.govOther trials for Immunoglobulin A vasculitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05951517Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein PurpuraSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- ACTIVE NOT RECRUITINGPHASE3NCT05329090Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA VasculitisHopital Foch
- RECRUITINGNANCT03647852Clinical Study on Strategy for Refractory Henoch-Schönlein PurpuraChildren's Hospital of Fudan University